Rockefeller Capital Management
IMNM icon

Rockefeller Capital Management’s Immunome IMNM Stock Holding History

Rockefeller Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87 Buy
+4
New +$89 ﹤0.01% 4640
2022
Q2 		– Sell
-20
Closed – – 4241
2022
Q1 		$0 Hold
20
– – ﹤0.01% 3966
2021
Q4 		$0 Hold
20
– – ﹤0.01% 3873
2021
Q3 		$0 Hold
20
– – ﹤0.01% 3753
2021
Q2 		$0 Hold
20
– – ﹤0.01% 3516
2021
Q1 		$0 Buy
+20
New +$497 ﹤0.01% 3315

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Rockefeller Capital Management's IMNM Position: Q1 2026 in Review

Rockefeller Capital Management opened a new position in Immunome (IMNM) in Q1 2026: 4 shares worth $87. The stake represents ﹤0.01% of the portfolio and ranks #4640 among its holdings. This is a return to the name: Rockefeller Capital Management previously reported a position in IMNM as recently as Q1 2022.

Rockefeller Capital Management first reported a position in IMNM in Q1 2021 and has held it in 6 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Rockefeller Capital Management held 4 shares of Immunome worth $87 as of Q1 2026.
  • Immunome was a new Rockefeller Capital Management position in Q1 2026.
  • Immunome made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4640 holding.
  • Rockefeller Capital Management first reported a position in Immunome in Q1 2021 and has held it in 6 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.